Prevention of Diabetes and Related Metabolic Disorders in High Risk Groups
预防高危人群的糖尿病和相关代谢紊乱
基本信息
- 批准号:MC_UU_00006/6
- 负责人:
- 金额:$ 440.24万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Intramural
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The prevalence of both obesity and diabetes is growing at an alarming rate. These conditions and their consequences probably represent the greatest public health challenge of this century. The goal of this programme is to contribute to efforts aimed at preventing the growing burden of diabetes, obesity and related metabolic disorders. To do this we are translating epidemiological knowledge into preventive action, and assessing the effectiveness of different preventive approaches. These approaches range from primary prevention, through earlier detection via screening, to the development and evaluation of interventions for those with the conditions.|The programme has a broad remit. It combines basic research to inform the development of future interventions. To better understand why some people are more active than others and to see how this relates to current health policy. This is illustrated by the following description of two of the research themes. Firstly, our work has demonstrated that higher levels of everyday physical activity reduce risk of diabetes. We are examining individual and environmental influences on physical activity in children and adults (2000 children and 15,000 middle aged adults Norfolk). They are assessed by using geographical information systems and questionnaires, as well as precise measurement of physical activity by accelerometers (measures movement & acceleration). At the same time we are evaluating different interventions to promote physical activity among people with diabetes and those at risk of developing diabetes and the effect of providing individuals with information about their levels of physical activity.|Earlier work from Unit colleagues confirmed that up to half of all people with type 2 diabetes remain undiagnosed. Many patients already have evidence of complications at diagnosis. Consequently, a key question for the health service in the UK and other countries is whether population screening for diabetes would be a cost-effective use of limited healthcare resources. We reviewed the evidence for and against screening on behalf of the National Screening Committee. We developed and tested simple methods of identifying those at high risk of having diabetes that utilise information routinely held in general practice computer records. We then incorporated this method into a trial of screening among 150,000 middle-aged residents of Cambridgeshire and surrounding counties. Preliminary results suggest that screening does not cause anxiety or depression, and patients detected by screening have high levels of modifiable cardiovascular risk factors which are reduced one year later, particularly in general practices being supported to provide intensive treatment.
肥胖症和糖尿病的患病率正在以惊人的速度增长。这些情况及其后果可能是本世纪最大的公共卫生挑战。该方案的目标是促进旨在预防糖尿病、肥胖症和相关代谢紊乱日益加重的负担的努力。为此,我们正在将流行病学知识转化为预防行动,并评估不同预防方法的有效性。这些方法包括初级预防,通过筛查进行早期发现,以及制定和评估针对有条件者的干预措施。|该方案的范围很广。它结合了基础研究,为未来干预措施的制定提供信息。为了更好地理解为什么有些人比其他人更活跃,并了解这与当前的卫生政策有何关系。以下对两个研究主题的描述说明了这一点。首先,我们的工作表明,较高水平的日常体力活动可以降低患糖尿病的风险。我们正在研究个体和环境对儿童和成人(2000名儿童和15,000名中年成人诺福克)身体活动的影响。他们通过使用地理信息系统和问卷进行评估,以及通过加速度计精确测量身体活动(测量运动和加速度)。与此同时,我们正在评估不同的干预措施,以促进糖尿病患者和有患糖尿病风险的人的身体活动,以及为个人提供有关其身体活动水平的信息的效果。|单位同事的早期工作证实,高达一半的2型糖尿病患者仍未确诊。许多患者在诊断时已经有并发症的证据。因此,英国和其他国家卫生服务的一个关键问题是,对糖尿病人群进行筛查是否是对有限医疗资源的经济有效利用。我们代表国家筛查委员会审查了支持和反对筛查的证据。我们开发并测试了识别糖尿病高危人群的简单方法,这些方法利用了常规计算机记录中的信息。然后,我们将这种方法纳入剑桥郡和周边县的150,000名中年居民的筛选试验中。初步结果表明,筛查不会引起焦虑或抑郁,通过筛查发现的患者具有高水平的可改变的心血管风险因素,这些风险因素在一年后会减少,特别是在支持提供强化治疗的一般做法中。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Acceptability and feasibility of an acceptance and commitment therapy-based guided self-help intervention for weight loss maintenance in adults who have previously completed a behavioural weight loss programme: the SWiM feasibility study protocol.
- DOI:10.1136/bmjopen-2021-058103
- 发表时间:2022-04-19
- 期刊:
- 影响因子:2.9
- 作者:Ahern, Amy L.;Richards, Rebecca;Jones, Rebecca A.;Whittle, Fiona;Mueller, Julia;Woolston, Jenny;Sharp, Stephen J.;Hughes, Carly A.;Hill, Andrew J.;Duschinsky, Robbie;Lawlor, Emma Ruth;Morris, Stephen;Fusco, Francesco;Brennan, Alan;Bostock, Jennifer;Griffin, Simon J.
- 通讯作者:Griffin, Simon J.
Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes: study protocol for the Glucose Lowering through Weight management (GLoW) randomised controlled trial.
糖尿病教育和行为体重管理计划与最近诊断为 2 型糖尿病的成人中的糖尿病教育计划的临床和成本效益:通过体重管理降低血糖 (GLoW) 随机对照试验的研究方案。
- DOI:10.1136/bmjopen-2019-035020
- 发表时间:2020
- 期刊:
- 影响因子:2.9
- 作者:Ahern AL
- 通讯作者:Ahern AL
Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes: study protocol for the Glucose Lowering through Weight...
糖尿病教育和行为体重管理计划与最近诊断为 2 型糖尿病的成人的糖尿病教育计划的临床和成本效益:通过体重降低血糖的研究方案...
- DOI:10.17863/cam.50941
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Ahern A
- 通讯作者:Ahern A
Acceptability and feasibility of an acceptance and commitment therapy-based guided self-help intervention for weight loss maintenance in adults who have previously completed a behavioural weight loss programme: the SWiM feasibility study protocol
基于接受和承诺疗法的指导自助干预对之前完成行为减肥计划的成年人维持减肥的可接受性和可行性:SWiM 可行性研究方案
- DOI:10.17863/cam.83782
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Ahern A
- 通讯作者:Ahern A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Simon Griffin其他文献
Assessing the value for money, from a policy maker perspective, of 24 randomised controlled trial designs for an online weight maintenance guided self-help intervention: an expected value of sample information analysis
从政策制定者的角度评估 24 种用于在线体重维持指导自助干预的随机对照试验设计的性价比:样本信息分析的期望值
- DOI:
10.1038/s41366-025-01804-7 - 发表时间:
2025-05-22 - 期刊:
- 影响因子:3.800
- 作者:
Penny Breeze;Katharine Pidd;Daniel Pollard;Shijie Ren;Sarah Bates;Chloe Thomas;Amy Ahern;Simon Griffin;Alan Brennan - 通讯作者:
Alan Brennan
SAT310 - Nutritional intake after liver transplant: systematic review with meta-analysis and meta-regression
SAT310 - 肝移植后的营养摄入:系统综述与荟萃分析和荟萃回归
- DOI:
10.1016/s0168-8278(22)01932-8 - 发表时间:
2022-07-01 - 期刊:
- 影响因子:33.000
- 作者:
Lynsey Spillman;Angela Madden;Holly Richardson;Fumiaki Imamura;Kirsten Rennie;Linda Oude Griep;Michael Allison;Simon Griffin - 通讯作者:
Simon Griffin
Correction to: longitudinal associations between built environment characteristics and changes in active commuting
- DOI:
10.1186/s12889-017-4843-1 - 发表时间:
2017-10-23 - 期刊:
- 影响因子:3.600
- 作者:
Lin Yang;Simon Griffin;Kay-Tee Khaw;Nick Wareham;Jenna Panter - 通讯作者:
Jenna Panter
Contraceptive knowledge: development of a valid measure and survey of pill users and general practioners.
避孕知识:制定有效的措施并对避孕药使用者和普通从业者进行调查。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
Paul Little;C. Glew;Jo Kelly;Simon Griffin;Nigel Dickson;C. Sadler - 通讯作者:
C. Sadler
How to embed qualitative research in trials: insights from the feasibility study of the SAFER trial programme
- DOI:
10.1186/s13063-022-06308-7 - 发表时间:
2022-05-12 - 期刊:
- 影响因子:2.000
- 作者:
Alison Powell;Sarah Hoare;Rakesh Modi;Kate Williams;Andrew Dymond;Cheryl Chapman;Simon Griffin;Jonathan Mant;Jenni Burt - 通讯作者:
Jenni Burt
Simon Griffin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Simon Griffin', 18)}}的其他基金
Characterising patterns and changes in physical activity in older people and their determinants and consequences
描述老年人身体活动的模式和变化及其决定因素和后果
- 批准号:
MR/K025147/1 - 财政年份:2013
- 资助金额:
$ 440.24万 - 项目类别:
Research Grant
Epidemiological contribution to primary and secondary prevention of diabetes and obesity
流行病学对糖尿病和肥胖症一级和二级预防的贡献
- 批准号:
MC_UU_12015/4 - 财政年份:2013
- 资助金额:
$ 440.24万 - 项目类别:
Intramural
Environmental and social influences on physical activity
环境和社会对身体活动的影响
- 批准号:
G0501294/1 - 财政年份:2006
- 资助金额:
$ 440.24万 - 项目类别:
Research Grant
相似海外基金
Using whole genome sequencing to identify non-coding elements associated with diabetes and related traits across ancestries
使用全基因组测序来识别与糖尿病相关的非编码元件和跨祖先的相关特征
- 批准号:
MR/Y003748/1 - 财政年份:2024
- 资助金额:
$ 440.24万 - 项目类别:
Research Grant
Novel therapies for obesity- or diabetes-related lymphatic dysfunction
肥胖或糖尿病相关淋巴功能障碍的新疗法
- 批准号:
10602589 - 财政年份:2023
- 资助金额:
$ 440.24万 - 项目类别:
Genetically harmonized dietary intake and causal relationships with diabetes-related outcomes
遗传协调的饮食摄入量及其与糖尿病相关结果的因果关系
- 批准号:
10730298 - 财政年份:2023
- 资助金额:
$ 440.24万 - 项目类别:
Role of Metallothionein 1 E in the protection of cystic fibrosis-related diabetes
金属硫蛋白 1 E 在保护囊性纤维化相关糖尿病中的作用
- 批准号:
10714873 - 财政年份:2023
- 资助金额:
$ 440.24万 - 项目类别:
Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease
循环硫化氢、糖尿病和糖尿病相关的心血管疾病
- 批准号:
10420827 - 财政年份:2022
- 资助金额:
$ 440.24万 - 项目类别:
Type II diabetes, related biomarkers and medications, and ovarian cancer risk
II 型糖尿病、相关生物标志物和药物以及卵巢癌风险
- 批准号:
10601473 - 财政年份:2022
- 资助金额:
$ 440.24万 - 项目类别:
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
2 型糖尿病中核因子红细胞 2 相关因子 2 (NRF2) 和钠-葡萄糖协同转运蛋白 2 (SGLT2) 表达的调节
- 批准号:
465229 - 财政年份:2022
- 资助金额:
$ 440.24万 - 项目类别:
Operating Grants
Type II diabetes, related biomarkers and medications, and ovarian cancer risk
II 型糖尿病、相关生物标志物和药物以及卵巢癌风险
- 批准号:
10551238 - 财政年份:2022
- 资助金额:
$ 440.24万 - 项目类别:
Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) and Regulation of Sodium-Glucose Co-Transporter 2 (SGLT2) Expression in Type 2 Diabetes
2 型糖尿病中核因子红细胞 2 相关因子 2 (NRF2) 和钠-葡萄糖协同转运蛋白 2 (SGLT2) 表达的调节
- 批准号:
468855 - 财政年份:2022
- 资助金额:
$ 440.24万 - 项目类别:
Operating Grants
Type II diabetes, related biomarkers and medications, and ovarian cancer risk
II 型糖尿病、相关生物标志物和药物以及卵巢癌风险
- 批准号:
10357268 - 财政年份:2022
- 资助金额:
$ 440.24万 - 项目类别: